Home › Non-Small Cell Lung Cancer › Texas › Sugar Land
Pag-aaral pangklinika para sa Non-Small Cell Lung Cancer sa Sugar Land, TX
Isang pag-aaral para sa Non-Small Cell Lung Cancer ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Sugar Land. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Nagre-recruitPhase 3
- Houston Methodist Sugar Land Hospital, Sugar Land
A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
Nagre-recruitPhase 1
- The University of Texas, MD Anderson Cancer Center - Sugar Land, Sugar Land
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
Nagre-recruitPhase 3
- The University of Texas, MD Anderson Cancer Center - Sugar Land, Sugar Land
- Texas Oncology - Gulf Coast, Sugar Land
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Nagre-recruitPhase 3
- Kelsey-Seybold Clinic - Fort Bend Campus, Sugar Land
- Texas Oncology - Gulf Coast, Sugar Land
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
Nagre-recruitPhase 3
- The University of Texas, MD Anderson Cancer Center - Sugar Land, Sugar Land
Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers
Nagre-recruitPhase 1/2
- Voyage Clinical, Sugar Land
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
Nagre-recruitPhase 3
- USO - Texas Oncology Gulf Coast, Sugar Land
Study of PF-07248144 in Advanced or Metastatic Solid Tumors
Nagre-recruitPhase 2
- MD Anderson, Sugar Land
Pag-aaral para sa Non-Small Cell Lung Cancer sa ibang lungsod
- Houston, TX145 pag-aaral
- New York City, NY121 pag-aaral
- Arlington, VA104 pag-aaral
- Nashville, TN97 pag-aaral
- Boston, MA90 pag-aaral
- Los Angeles, CA87 pag-aaral
- St. Louis, MO73 pag-aaral
- Chicago, IL61 pag-aaral
- Baltimore, MD60 pag-aaral
- San Antonio, TX59 pag-aaral
- Columbus, OH57 pag-aaral
- Washington, DC55 pag-aaral
Iba pang pag-aaral sa Sugar Land
- Obesity11 pag-aaral
- Overweight10 pag-aaral
- Mga Karamdaman sa Labis na Pagkatulog7 pag-aaral
- Kanser sa Suso7 pag-aaral
- Atopic Dermatitis (Eczema)6 pag-aaral
- Steatotic Liver Disease6 pag-aaral
- Kanser sa Baga6 pag-aaral
- Type 2 Diabetes5 pag-aaral
- Mga Gulo sa Tulog5 pag-aaral
- Pneumococcal Infections4 pag-aaral
- Narcolepsy4 pag-aaral
- Metastatic Cancer4 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.